These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4036927)

  • 1. Pulmonary and renal responses to furosemide in infants with stage III-IV bronchopulmonary dysplasia.
    Patel H; Yeh TF; Jain R; Pildes R
    Am J Dis Child; 1985 Sep; 139(9):917-9. PubMed ID: 4036927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral excretion following furosemide compared with bumetanide therapy in premature infants.
    Shankaran S; Liang KC; Ilagan N; Fleischmann L
    Pediatr Nephrol; 1995 Apr; 9(2):159-62. PubMed ID: 7794709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of metolazone to overcome tolerance to furosemide in infants with bronchopulmonary dysplasia.
    Segar JL; Robillard JE; Johnson KJ; Bell EF; Chemtob S
    J Pediatr; 1992 Jun; 120(6):966-73. PubMed ID: 1593359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia.
    Rush MG; Engelhardt B; Parker RA; Hazinski TA
    J Pediatr; 1990 Jul; 117(1 Pt 1):112-8. PubMed ID: 2196353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal response to frusemide in preterm infants with respiratory distress syndrome during the first three postnatal days.
    Yeh TF; Raval D; John E; Pildes RS
    Arch Dis Child; 1985 Jul; 60(7):621-6. PubMed ID: 4026357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized furosemide in infants with bronchopulmonary dysplasia.
    Rastogi A; Luayon M; Ajayi OA; Pildes RS
    J Pediatr; 1994 Dec; 125(6 Pt 1):976-9. PubMed ID: 7996373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal response to furosemide in very low birth weight infants during chronic administration.
    Mirochnick MH; Miceli JJ; Kramer PA; Chapron DJ; Raye JR
    Dev Pharmacol Ther; 1990; 15(1):1-7. PubMed ID: 2242705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diuretics in the neonatal period].
    Guignard JP; Dubourg L; Gouyon JB
    Rev Med Suisse Romande; 1995 Aug; 115(8):583-90. PubMed ID: 7569538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early furosemide therapy in premature infants (less than or equal to 2000 gm) with respiratory distress syndrome: a randomized controlled trial.
    Yeh TF; Shibli A; Leu ST; Raval D; Pildes RS
    J Pediatr; 1984 Oct; 105(4):603-9. PubMed ID: 6384452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 6-hour infusion versus bolus furosemide in premature infants.
    Reiter PD; Makhlouf R; Stiles AD
    Pharmacotherapy; 1998; 18(1):63-8. PubMed ID: 9469683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia.
    Engelhardt B; Elliott S; Hazinski TA
    J Pediatr; 1986 Dec; 109(6):1034-9. PubMed ID: 3537245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Udder edema in cattle: effects of diuretics (furosemide, hydrochlorothiazide, acetazolamide, and 50% dextrose) on serum and urine electrolytes.
    Vestweber JG; al-Ani FK; Johnson DE
    Am J Vet Res; 1989 Aug; 50(8):1323-8. PubMed ID: 2782714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
    Kugelman A; Durand M; Garg M
    Pediatrics; 1997 Jan; 99(1):71-5. PubMed ID: 8989341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacologic effects of furosemide therapy in the low-birth-weight infant.
    Ross BS; Pollak A; Oh W
    J Pediatr; 1978 Jan; 92(1):149-52. PubMed ID: 22591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia.
    Kao LC; Durand DJ; McCrea RC; Birch M; Powers RJ; Nickerson BG
    J Pediatr; 1994 May; 124(5 Pt 1):772-81. PubMed ID: 8176568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates.
    Pai VB; Nahata MC
    Ann Pharmacother; 2000 Mar; 34(3):386-92. PubMed ID: 10917388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia.
    Kao LC; Warburton D; Sargent CW; Platzker AC; Keens TG
    J Pediatr; 1983 Oct; 103(4):624-9. PubMed ID: 6620024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of renal excretory function after furosemide or ethacrynic acid administration to unanaesthetized dogs after mannitol infusion or chronic renal denervation.
    Girchev R; Kabakchieva E; Vrabchev N; Natcheff N; Natochin Y
    Acta Physiol Hung; 1985; 65(2):137-48. PubMed ID: 3920869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of insulin-induced changes in the renal response to furosemide in normal subjects.
    Sechi LA; Marigliano A; Tedde R
    Miner Electrolyte Metab; 1991; 17(6):383-9. PubMed ID: 1823389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.